Medicine composition for treating cat fatty liver syndrome and preparation method thereof

A fatty liver and syndrome technology, applied in the field of pharmaceutical compositions for treating feline fatty liver syndrome, can solve the problems of unsatisfactory curative effect, cure the symptoms but not the root cause, etc., and achieves increasing coronary blood flow, enhancing immune function, increasing The effect of myocardial blood supply

Inactive Publication Date: 2016-01-20
JILIN AGRICULTURAL UNIV
View PDF2 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0006] For the treatment of this disease, Western medicine is mostly used in clinic to reduce the fat content in the cat liver. Although it can temporarily delay the disease, it treats the symptoms but not the root cause, and the curative effect is not satisfactory.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Medicine composition for treating cat fatty liver syndrome and preparation method thereof
  • Medicine composition for treating cat fatty liver syndrome and preparation method thereof
  • Medicine composition for treating cat fatty liver syndrome and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0046] Components by weight: 60 parts of sorrel, 60 parts of chinensis, 60 parts of chicken bone grass, 60 parts of gentian, 60 parts of cassia seed, 50 parts of evening primrose, 50 parts of white peony, 50 parts of angelica, 50 parts of Zhishouwu 40 parts of Poria cocos, 40 parts of Atractylodes macrocephala, 40 parts of seaweed, 35 parts of safflower, 35 parts of Panax notoginseng, 35 parts of Chinese sage, 30 parts of Kudingcha, 30 parts of Sophora japonica, 8 parts of Dongbao Gantai tablets, 4 servings of Tiopronin Tablets and 8 servings of Gan Tai Le Tablets.

Embodiment 2

[0048] Components by weight: 40 parts of sorrel, 40 parts of Sorrel, 40 parts of chicken bone grass, 40 parts of gentian, 40 parts of cassia seed, 30 parts of evening primrose, 30 parts of white peony root, 30 parts of angelica, 30 parts of Zhishouwu 20 parts of Poria cocos, 20 parts of Atractylodes macrocephala, 20 parts of seaweed, 15 parts of safflower, 15 parts of Panax notoginseng, 15 parts of Chinese sage, 10 parts of Kudingcha, 10 parts of Sophora japonica, 8 parts of Dongbao Gantai tablets, 4 servings of Tiopronin Tablets and 8 servings of Gan Tai Le Tablets.

Embodiment 3

[0050] Components by weight: 50 parts of sorrel, 50 parts of Sorrel, 50 parts of chicken bone grass, 50 parts of gentian, 50 parts of cassia seed, 40 parts of evening primrose, 40 parts of white peony root, 40 parts of angelica, 40 parts of Zhishouwu 30 parts of Poria cocos, 30 parts of Atractylodes macrocephala, 30 parts of seaweed, 25 parts of safflower, 25 parts of Panax notoginseng, 25 parts of Chinese sage, 20 parts of Kudingcha, 20 parts of Sophora japonica, 8 parts of Dongbao Gantai tablets, 4 servings of Tiopronin Tablets and 8 servings of Gan Tai Le Tablets.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a medicine composition for treating a cat fatty liver syndrome. The medicine composition is prepared from, by weight, 40-60 parts of creeping oxalis, 40-60 parts of tuhuanglian solution, 40-60 parts of abrus cantoniensis hance, 40-60 parts of felwort, 40-60 parts of semen cassia, 30-50 parts of evening primrose, 30-50 parts of radix paeoniae alba, 30-50 parts of angelica sinensis, 30-50 parts of prepared fleece flower roots, 20-40 parts of poria cocos, 20-40 parts of atractylodes macrocephala koidz, 20-40 parts of marine algae, 15-35 parts of flos carthami, 15-35 parts of pseudo-ginseng, 15-35 parts of salvia chinensis, 10-30 parts of broadleaf holly leaves, 10-30 parts of sophora japonica, 8 parts of compound methionine choline tablets, 4 parts of tiopronin tablets and 8 parts of glucurolactone tablets. It is indicated through clinical application that the medicine composition has special effects on treating the cat fatty liver syndrome. It is proved through clinic treatment statistics that the cure rate can reach 93.33%, and the total effective rate is 100.00%. A Chinese and western medicine composition prepared from the medicine composition is more obvious in effect, wide in ingredient source, low in cost, high in cure rate, free of medicine residues, free of toxic and side effects and easy for a cat to absorb, the cat fatty liver syndrome can be effectively treated, and the curative effect is very remarkable.

Description

technical field [0001] The invention relates to the technical field of traditional Chinese veterinary medicine, in particular to a pharmaceutical composition for treating cat fatty liver syndrome. Background technique [0002] Feline fatty liver syndrome is a disease in which the liver enlarges due to lipid storage in liver cells. Because the cat's liver has a special ability to accumulate fat, the disease is specific to cats and can easily cause liver cell damage. Clinical data prove that this disease is the most common liver disease in cats. Most cats with fatty liver develop liver disease, which is the most common form of liver disease in cats. Fatty liver disease in cats is more serious than that in dogs, and it often leads to death if it is not treated in time. The disease does not distinguish between breeds, and the incidence rate of female cats is higher than that of male cats. It is more common in elderly cats who do not eat food for a period of time before the on...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/71A61K36/704A61P1/16A61K31/195A61K31/198A61K31/7048A61K31/455A61K31/51A61K31/525A61K31/197A61K31/4415
Inventor 温伟蔡亚南赵权魏秀河任玉德王振民
Owner JILIN AGRICULTURAL UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products